A European survey of perendoscopic treatment of biliary complications in patients with alveolar echinococcosis

Ambregna, Sylvain; Koch, Stéphane; Sulz, Michael Christian; Grüner, Beate; Öztürk, Sümeyra; Chevaux, Jean–Baptiste; Sulima, Małgorzata; Gottardi, Andrea De; Napoléon, Bertrand; Abergel, Armand; Bichard, Philippe; Boytchev, Isabelle; Deprez, Pierre Henri; Dumortier, J; Frossard, Jean‐Louis; Kull, Eric; Meny, B; Moradpour, Darius; Prat, Frédéric; Vanbiervliet, Geoffroy; Thévenot, Thierry; Vuitton, Dominique A.; Bresson‐Hadni, Solange; Vuitton, Lucine

doi:10.1080/14787210.2017.1252260

Cited by 28 publications

(23 citation statements)

References 26 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…A European survey of perendoscopic procedures (through ERCP) to treat biliary complications of AE in 18 clinical centers showed that such procedures are now used routinely and are generally successful in alleviating symptoms and in maintaining long-term permeability of the biliary strictures; to achieve good results, extensive saline lavage of the bile ducts, which removes necrotic debris and intrahepatic biliary stones that are common in such patients, and the use of multiple plastic stents are recommended (211) (Fig. 6).…”

Section: Treatment Of Aementioning

confidence: 99%

“…6). Although there have been no specific studies assessing the quality of life of patients receiving such treatment, we may anticipate that this has markedly contributed to the improved quality of life of those patients with chronic biliary obstruction and multiple cholangitis episodes; in the past, more than 10 reoperations in a single patient were not uncommon, and most patients had a very uncomfortable external biliary drainage tube for life (211).…”

Section: Treatment Of Aementioning

confidence: 99%

See 1 more Smart Citation

Echinococcosis: Advances in the 21st Century

Wen¹,

Vuitton²,

et al. 2019

Self Cite

View full text Add to dashboard Cite

SUMMARY Echinococcosis is a zoonosis caused by cestodes of the genus Echinococcus (family Taeniidae). This serious and near-cosmopolitan disease continues to be a significant public health issue, with western China being the area of highest endemicity for both the cystic (CE) and alveolar (AE) forms of echinococcosis. Considerable advances have been made in the 21st century on the genetics, genomics, and molecular epidemiology of the causative parasites, on diagnostic tools, and on treatment techniques and control strategies, including the development and deployment of vaccines. In terms of surgery, new procedures have superseded traditional techniques, and total cystectomy in CE, ex vivo resection with autotransplantation in AE, and percutaneous and perendoscopic procedures in both diseases have improved treatment efficacy and the quality of life of patients. In this review, we summarize recent progress on the biology, epidemiology, diagnosis, management, control, and prevention of CE and AE. Currently there is no alternative drug to albendazole to treat echinococcosis, and new compounds are required urgently. Recently acquired genomic and proteomic information can provide a platform for improving diagnosis and for finding new drug and vaccine targets, with direct impact in the future on the control of echinococcosis, which continues to be a global challenge.

show abstract

Section: Treatment Of Aementioning

confidence: 99%

Section: Treatment Of Aementioning

confidence: 99%

Echinococcosis: Advances in the 21st Century

Wen¹,

Vuitton²,

et al. 2019

Self Cite

View full text Add to dashboard Cite

show abstract

“…In AE, partial resection of AE lesions was commonly performed, associated with surgical biliary drainage, until retrospective analysis of cases from European teams showed that such interventions were followed by an increased rate of complications and decreased survival of the patients (Buttenschoen et al, 2009;Kadry et al, 2005). Palliative surgical interventions may be replaced by percutaneous or perendoscopic interventions of drainage and/or stenting, especially to alleviate complications of biliary obstruction or to treat bacterial infection of the central necrotic cavity in AE lesions (Ambregna et al, 2017;Vuitton et al, 2016). Whenever possible, any intervention should be associated with ABZ treatment: 1 to 3 months after any interventions for CE, 2 years after radical resection for AE.…”

Section: Treatment Optionsmentioning

confidence: 99%

Echinococcus spp.

Vuitton¹,

Zhang²,

Giraudoux³

2019

Water and Sanitation for the 21st Century: Health and Microbiological Aspects of Excreta and Wastewater Management (Global Wate

View full text Add to dashboard Cite

The designations employed and the presentation of material throughout this publication do not imply the expression of any opinion whatsoever on the part of UNESCO concerning the legal status of any country, territory, city or area or of its authorities, or concerning the delimitation of its frontiers or boundaries. The ideas and opinions expressed in this publication are those of the authors; they are not necessarily those of UNESCO and do not commit the Organization.

show abstract

“…Il est désormais possible de réaliser par voie endoscopique une désobstruction des canaux biliaires envahis par les lésions parasitaires, d'évacuer les débris qui transitent par ces canaux, et les calculs qui s'y sont formés, et de poser des stents en plastique pour rétablir leur perméabilité.P ourr estaurer définitivement cette perméabilité,lamise en place de plusieurs stents à la fois, disposés«en fagots » et la répétition de cette mise en place de stents, sont indispensables. C'est ce que vient de montrer une enquête rétrospective européenne initiéep ar le service de gastroentérologie-endoscopie digestived uC HU de Besançon qui révèle aussi que cette technique est désormais de pratique courante dans les centres européense n charge des patients atteints d'EA [44].…”

Section: L'endoscopie Biliaire Interventionnelle :I Ndiquéep Our Le Tunclassified

Echinococcose alvéolaire : actualités 2016

Bresson‐Hadni¹,

Vuitton²

2016

Hegel

Self Cite

View full text Add to dashboard Cite

L'échinococcose alvéolaire (EA) est une cestodose larvaire rare, due au développement dans le foie de la larved ' Echinococcus multilocularis.S ap rogression s'apparente à celle d'un cancer à marche lente. En France, les caractéristiques épidémiologiques de l'EA se sont modifiées récemment. Les foyers endémiques restent localisés à l'Est et au Centre du Te rritoire, mais la limite occidentale de la zone d'endémief rançaise dépasse désormais Paris et concerne également les zones urbaines. Le registre français des cas indique par ailleurs une augmentation de l'incidence annuelle. Elle est probablement surtout la conséquence d'une amélioration significativedes techniques de diagnostic, en particulier de l'échographie, examen de première ligne pour le diagnostic de cette affection. Le développement de thérapeutiques immunosuppressives (chimiothérapie, biothérapie) pour diverses pathologies peut fournir une deuxième explication, avecl 'observation croissante de cas d'EA découverts en situation d'immunosuppression. La maladie est repéréeplus tôtdans son cours évolutif,t r è ss ouvent à un stade asymptomatique. L'ictère qui, par le passé,r é v é lait l'EA dans la moitié des cas, n'est aujourd'hui que trèsr arement présent au diagnostic. La chirurgie est restée jusque dans les années 1980, la seule et unique solution pour son traitement, souvent palliatif.Des options complémentaires, ou distinctes, sont apparues au cours de ces trente dernières années : administration d'albendazole exerçant un effet parasitostatique, radiologie interventionnelle, transplantation hépatique en cas d'EA évoluées. To utes ces acquisitions, associées à un diagnostic généralement plus précoce, aux progrèsd es techniques d'imagerie et de la chirurgie hépatobiliaire ainsi qu'à une approche multidisciplinaire de cette prise en charge, ont permis d'améliorer considérablement le pronostic. mots-clésEchinococcose alvéolaire ; Echinococcus multilocularis ;P arasitose hépatique ;B enzimidazolés; Albendazole ;C hirurgie ;R adiologiei nterventionnelle Abstract Alveolar echinococcosis (AE) is ar are larval cestodosis infestation caused by the intra-hepatic development of Echinococcus multilocularis larva. Its progression in the liver is similar to as lowgrowing cancer. Recently in France, the epidemiological characteristics of AE evolved. The endemic areas are stilll ocated in the East and in the Center of the territory, but the western limit of the French endemic zone now extends beyond Paris and includes other urban areas. The French Registry also indicates an increase of the annual incidence rate. Above all, this phenomenon is probably due to the major improvement of the diagnostic techniques -especially liver ultrasound exam, that proved to be the first line exam to diagnose this parasitic disease. This could also be explained by the development of immunosuppressive therapeutics like chemotherapy or biotherapy to treat various pathological conditions, which is linked with the growing observation of AE discovered in immunosuppressive situations. Today...

show abstract

A European survey of perendoscopic treatment of biliary complications in patients with alveolar echinococcosis

Abstract: European centers use perendoscopic biliary drainage as an efficient and safe alternative to surgery to treat AE biliary complications. Insertion of multiple plastic stents delays stent occlusion and leads to effective and prolonged bile duct patency.

Cited by 28 publications

References 26 publications

Echinococcosis: Advances in the 21st Century

Echinococcosis: Advances in the 21st Century

Echinococcus spp.

Echinococcose alvéolaire : actualités 2016

Contact Info

Product

Resources

About